Stem Holdings (Stem Holdings) Debt-to-Revenue : N/A (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Stem Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $2.34 Mil. Stem Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Stem Holdings's annualized Revenue for the quarter that ended in Sep. 2023 was $-47.13 Mil. Stem Holdings's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was -0.05.

Stem Holdings Debt-to-Revenue Historical Data

The historical data trend for Stem Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Debt-to-Revenue Chart

Stem Holdings Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Revenue

Get a 7-Day Free Trial

2.44

0.94

0.54

N/A

Stem Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	0.71	0.73	0.76	N/A

Competitive Comparison of Stem Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stem Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Debt-to-Revenue falls into.

Stem Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Stem Holdings's Debt-to-Revenue for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.34	+	0)	/	N/A
	=	N/A

Stem Holdings's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.34	+	0)	/	-47.132
	=	-0.05

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.

Stem Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Stem Holdings (Stem Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

STEM:Canada

Address

2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431

Website

https://www.stemholdings.com

Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.

Executives

Matthew Cohen	director, officer: CEO & CFO	1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek	director	7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin	director	41ULUA PLACE, HAIKU HI 96708
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj	director	438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold	director	3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder	director	408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender	director	506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk	director, officer: President	9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard	director, officer: CFO	3496 FARIVIEW WAY, WEST LINN OR 97068